I agree that this site is using cookies. You can find further informations here.
X
Harb, Wael
99  results:
Search for persons X
?
1

First-in-human phase I dose escalation trial of the first-i..:

Mahalingam, Devalingam ; Harb, Wael ; Patnaik, Amita...
Communications Medicine.  4 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Results from phase 1 of the MANIFEST clinical trial to eval..:

Stein, Eytan M. ; Fathi, Amir T. ; Harb, Wael A....
Leukemia & Lymphoma.  65 (2024)  4 - p. 503-510 , 2024
Link: https://doi.org/10.1080/..
 
?
3

Safety and efficacy of the tumor-selective adenovirus enade..:

Fakih, Marwan ; Harb, Wael ; Mahadevan, Daruka...
Journal for ImmunoTherapy of Cancer.  11 (2023)  4 - p. e006561 , 2023
Link: https://doi.org/10.1136/..
 
?
4

Safety and Efficacy of a DNA Oligonucleotide Therapy in Pat..:

Westin, Jason ; Maris, Michael B ; Jacobson, Caron A...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  1 - p. 52-59 , 2022
Link: https://doi.org/10.1016/..
 
?
5

A Phase 2 Study of PNT2258 for Treatment of Relapsed or Ref..:

Harb, Wael ; Lakhani, Nehal J. ; Messmann, Richard..
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  12 - p. 823-830 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing E..:

Spira, Alexander ; Hansen, Aaron R. ; Harb, Wael A....
Targeted Oncology.  16 (2021)  4 - p. 461-469 , 2021
Link: https://doi.org/10.1007/..
 
?
7

First-in-Human Phase I Study of Envafolimab, a Novel Subcut..:

Papadopoulos, Kyriakos P. ; Harb, Wael ; Peer, Cody J....
The Oncologist.  26 (2021)  9 - p. e1514-e1525 , 2021
Link: https://doi.org/10.1002/..
 
?
8

A phase 2 trial of consolidation pembrolizumab following co..:

Durm, Greg A. ; Jabbour, Salma K. ; Althouse, Sandra K....
Cancer.  126 (2020)  19 - p. 4353-4361 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Randomized Phase II Trial of Seribantumab in Combination wi..:

Sequist, Lecia V. ; Gray, Jhanelle Elaine ; Harb, Wael A....
The Oncologist.  24 (2019)  8 - p. 1095-1102 , 2019
Link: https://doi.org/10.1634/..
 
?
10

A Phase Ib, open-label, dose-finding study of alpelisib in ..:

Rodon, Jordi ; Curigliano, Giuseppe ; Delord, Jean-Pierre...
Oncotarget.  9 (2018)  60 - p. 31709-31718 , 2018
Link: https://doi.org/10.18632..
 
?
11

P2.06-011 Phase 2 Study of MM-121 plus Chemotherapy vs. Che..:

Sequist, Lecia ; Anderson, Ian ; Atmaca, Akin...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1075-S1076 , 2017
Link: https://doi.org/10.1016/..
 
?
12

A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, C..:

Boccia, Ralph ; Bessudo, Alberto ; Agajanian, Richy...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e14 , 2017
Link: https://doi.org/10.1016/..
 
?
13

A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, C..:

Boccia, Ralph V. ; Bessudo, Alberto ; Agajanian, Richy...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  7 - p. 433-437 , 2017
Link: https://doi.org/10.1016/..
 
?
14

P3.02c-027 Phase I and PK Study of the Folate Receptor-Targ..:

Edelman, Martin ; Sachdev, Jasgit ; Harb, Wael...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1288-S1289 , 2017
Link: https://doi.org/10.1016/..
 
?
15

MA09.06 Viagenpumatucel-L Bolsters Response to Nivolumab Th..:

Morgensztern, Daniel ; Harb, Wael ; Schalper, Kurt...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S394-S395 , 2017
Link: https://doi.org/10.1016/..
 
1-15